bpc-157 genotoxicity ames test All Mechanisms Ames Test and Genotoxicity Testing

In some embodiments, administration of formulation or composition or device described herein reduces damage to cochlear structures caused by underlying conditions (e.g., bacterial meningitis, autoimmune ear disease (AIED)) allowing for successful cochlear device implantation

Building a Therapeutic Relationship A strong therapeutic relationship is foundational to effective therapy

MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors

These lipidation and amino acid substitutions solve two fundamental problems with native human amylin: its extremely short plasma half-life (measured in minutes) and its well-documented tendency toward amyloid fibril formation